In the last 90 days, Caris Life Sciences Inc. saw one insider buy transaction totaling $501,426.45. This contrasts with earlier planned sales by an officer in December 2025. The company's stock has experienced a 3.0% decrease over the past 90 days, trading near its 52-week low.